Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 11,716,260 | 11,247,290 | 11,700,730 | 12,087,020 | 12,060,960 |
| Cost of Goods | 3,512,178 | 3,443,990 | 3,752,590 | 4,099,030 | 4,100,860 |
| Gross Profit | 8,204,078 | 7,803,300 | 8,269,699 | 8,887,600 | 8,519,720 |
| Operating Expenses | 6,020,872 | 5,222,689 | 5,901,719 | 5,803,790 | 6,365,100 |
| Operating Income | 2,183,385 | 2,581,601 | 2,047,012 | 2,184,229 | 1,595,860 |
| Interest Expense | 170,918 | 182,220 | 222,750 | 216,630 | 191,370 |
| Other Income | 35,983 | 336,669 | -732,362 | 1,165,781 | 28,650 |
| Pre-tax Income | 2,048,450 | 2,736,050 | 1,091,900 | 3,133,380 | 1,433,140 |
| Income Tax | 479,342 | 650,250 | -589,630 | 563,520 | 292,090 |
| Net Income Continuous | 1,569,107 | 2,414,381 | 1,886,961 | 2,803,227 | 1,453,268 |
| Minority Interests | 64,255 | N/A | N/A | N/A | N/A |
| Net Income | $1,504,852 | $2,414,381 | $1,886,961 | $2,803,227 | $1,453,268 |
| EPS Basic Total Ops | 0.57 | 0.91 | 0.71 | 1.05 | 0.56 |
| EPS Basic Continuous Ops | 0.60 | 0.91 | 0.71 | 1.05 | 0.56 |
| EPS Diluted Total Ops | 0.57 | 0.91 | 0.71 | 1.05 | 0.56 |
| EPS Diluted Continuous Ops | 0.60 | 0.91 | 0.71 | 1.05 | 0.56 |
| EBITDA(a) | $5,370,433 | $2,581,601 | $2,047,012 | $2,184,229 | $1,595,860 |